Status:
UNKNOWN
Study of Accurate Diagnosis and Treatment of Peutz-Jeghers Syndrome
Lead Sponsor:
Yiqi Du
Conditions:
Peutz-Jeghers Syndrome
Eligibility:
All Genders
5-70 years
Phase:
NA
Brief Summary
The mutation of STK11 has been regcognized to be the major cause of Peutz-Jeghers syndrome (PJS).The aim of this study was to confirm the mutation rate of gene associated with gastrointestinal maligna...
Detailed Description
All patients diagnosed as PJS were enrolled and accepted second generation gene sequencing with their blood specimens. Then all patients allocated into gene mutation group and no gene mutation group a...
Eligibility Criteria
Inclusion
- Subject with ages from 18-70 years old.
- Subject diagnosed with Peutz-Jeughers syndrome.
- Subject without hypertension, diabetes and other gastrointestinal diseases.
- The consent form has been signed.
Exclusion
- Subject is younger than 18 years or older than 70 years.
- Subject with hypertension,diabetes and other gastrointestinal diseases.
- Subject taken or adminstered medicine associated with digestive function during latest 1 month.
- Pregnant women.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03806075
Start Date
March 1 2018
End Date
September 1 2021
Last Update
January 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, China, 200433